Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

US Army
UBS
Daiichi Sankyo
QuintilesIMS
Healthtrust
Cantor Fitzgerald

Generated: September 23, 2019

DrugPatentWatch Database Preview

Patent: 8,022,064

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,022,064
Title:Phenylpentadienoyl derivatives and their use as PAR 1 antagonists
Abstract: The present invention relates to compounds of general formula (I): wherein: R.sub.1 and R.sub.2, identical or different, represent: an atom of hydrogen or halogen, CN or NO.sub.2, with R.sub.1 and R.sub.2 not representing hydrogen simultaneously, m represents: 1 or 2 n represents: 0, 1 or 2 R.sub.3 represents: phenyl substituted or not by one or more residues chosen among halogen, hydroxyl or C.sub.1-C.sub.6 alkyl; C.sub.2-C.sub.6 alkyl substituted or not by one or more residues chosen among halogen or hydroxyl; cycloalkyl; pyridine; thiophene; pyrrole substituted or not by C.sub.1-C.sub.6 alkyl; thiazole or furan; or the therapeutically-acceptable salts or solvates thereof. ##STR00001##
Inventor(s): Perez; Michel (Castres, FR), Lamothe; Marie (Castres, FR), Le Grand; Bruno (Lautrec, FR), Letienne; Robert (Castres, FR)
Assignee: Pierre Fabre Medicament (Boulogne-Billancourt, FR)
Application Number:12/305,447
Patent Claims:see list of patent claims

Details for Patent 8,022,064

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Centocor Inc REOPRO abciximab INJECTABLE; INJECTION 103575 001 1994-12-22 ➤ Sign Up Pierre Fabre Medicament (Boulogne-Billancourt, FR) 2026-06-19 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Farmers Insurance
Queensland Health
AstraZeneca
Fuji
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.